-
Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia.
Santos LL, Wertaschnigg D, Rolnik DL, Da Silva Costa F, Syngelaki A, Dimitriadis E, Nicolaides KH.
Placenta 2020;103:76-81. pdf -
Second- and third-trimester serum levels of growth-differentiation factor-15 in prediction of pre-eclampsia.
Wertaschnigg D, Rolnik DL, Nie G, Teoh SSY, Syngelaki A, da Silva Costa F, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;56:879-884. pdf -
Galectin-7 Impairs Placentation and Causes Preeclampsia Features in Mice.
Menkhorst E, Zhou W, Santos LL, Delforce S, So T, Rainczuk K, Loke H, Syngelaki A, Varshney S, Williamson N, Pringle K, Young MJ, Nicolaides KH, St-Pierre Y, Dimitriadis E.
Hypertension 2020;76:1185-1194. pdf -
First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D, Biris D, Karampitsakos T, Nicolaides KK, Kametas NA.
Am J Obstet Gynecol 2020;222:374.e1-374.e9. pdf -
Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery.
Sharabi-Nov A, Kumar K, Fabjan Vodušek V, Premru Sršen T, Tul N, Fabjan T, Meiri H, Nicolaides KH, Osredkar J.
Fetal Diagn Ther 2020;47:471-484. pdf -
Chronic hypertension: effect of blood pressure control on pregnancy outcome.
Panaitescu AM, Roberge S, Nicolaides KH.
J Matern Fetal Neonatal Med 2019;32:857-863. pdf -
Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Ciobanou A, Jabak S, De Castro H, Frei L, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;54:79-86. pdf -
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;52:52-59. pdf -
Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age.
Madar-Shapiro L, Karady I, Trahtenherts A, Syngelaki A, Akolekar R, Poon L, Cohen R, Sharabi-Nov A, Huppertz B, Sammar M, Juhasz K, Than NG, Papp Z, Romero R, Nicolaides KH, Meiri H.
Fetal Diagn Ther 2018;43(4):250-265. pdf -
Peripheral blood cell microRNA quantification during the first trimester predicts preeclampsia: Proof of concept.
Winger EE, Reed JL, Ji X, Nicolaides K.
PLoS One 2018;13:e0190654. pdf -
Early Detection of Preeclampsia Using Circulating Small non-coding RNA.
Yoffe L, Gilam A, Yaron O, Polsky A, Farberov L, Syngelaki A, Nicolaides K, Hod M, Shomron N.
Sci Rep 2018;8:3401. pdf -
Chronic hypertension: first-trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age.
Nzelu D, Dumitrascu-Biris D, Nicolaides KH, Kametas NA.
Am J Obstet Gynecol 2018;218:337.e1-337.e7. pdf -
Chronic hypertension and adverse pregnancy outcomes: a cohort study.
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:228-235. pdf -
Uterine artery pulsatility index at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:308-15. pdf -
Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:203-9. pdf -
Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valino N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:194-202. pdf -
Maternal hemoglobin at 27-29 weeks' gestation and severity of pre-eclampsia.
Cordina M, Bhatti S, Fernandez M, Syngelaki A, Nicolaides KH, Kametas NA.
J Matern Fetal Neonatal Med 2015;27:1-6. pdf -
Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia.
Khalil A, Maiz N, Garcia-Mandujano R, Elkhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:190-8. pdf -
Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Ther 2014;35:249-57. pdf -
Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Ther 2014;36:106-16.. pdf